Medtronic plc Files 2024 Annual Report
Ticker: MDT · Form: 10-K · Filed: 2024-06-20T00:00:00.000Z
Sentiment: neutral
Topics: 10-K, annual-report, medical-devices
TL;DR
Medtronic's 2024 10-K is in: check financials for the medical device giant.
AI Summary
Medtronic plc filed its 10-K for the fiscal year ending April 26, 2024, reporting on its financial performance and business operations. The company, headquartered in Dublin, Ireland, operates within the electromedical and electrotherapeutic apparatus industry. Key financial data and operational details are presented in this comprehensive annual report.
Why It Matters
This filing provides investors and stakeholders with a detailed overview of Medtronic's financial health, strategic initiatives, and risk factors for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a large, publicly traded medical device company, Medtronic faces inherent risks related to regulatory changes, competition, and product innovation.
Key Numbers
- FY 2024 — Fiscal Year (Reporting period covered by the 10-K)
Key Players & Entities
- Medtronic plc (company) — Filer of the 10-K report
- 20240426 (date) — Fiscal year end date
- 20240620 (date) — Filing date
- Dublin, Ireland (location) — Company headquarters
- 3845 (industry_code) — Standard Industrial Classification for Electromedical & Electrotherapeutic Apparatus
FAQ
What is Medtronic's primary industry classification?
Medtronic plc is classified under Standard Industrial Classification code 3845, which pertains to Electromedical & Electrotherapeutic Apparatus.
When did Medtronic plc's fiscal year 2024 end?
Medtronic plc's fiscal year 2024 ended on April 26, 2024.
What is the filing date of this 10-K report?
This 10-K report was filed on June 20, 2024.
Where is Medtronic plc headquartered?
Medtronic plc is headquartered in Dublin, Ireland.
What is the SEC file number for Medtronic plc?
The SEC file number for Medtronic plc is 001-36820.
From the Filing
0001613103-24-000072.txt : 20240620 0001613103-24-000072.hdr.sgml : 20240620 20240620161651 ACCESSION NUMBER: 0001613103-24-000072 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 162 CONFORMED PERIOD OF REPORT: 20240426 FILED AS OF DATE: 20240620 DATE AS OF CHANGE: 20240620 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Medtronic plc CENTRAL INDEX KEY: 0001613103 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 FISCAL YEAR END: 0426 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36820 FILM NUMBER: 241056445 BUSINESS ADDRESS: STREET 1: 20 ON HATCH, LOWER HATCH STREET CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: 01135314381700 MAIL ADDRESS: STREET 1: 20 ON HATCH, LOWER HATCH STREET CITY: DUBLIN STATE: L2 ZIP: 2 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Ltd DATE OF NAME CHANGE: 20150112 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Holdings Ltd DATE OF NAME CHANGE: 20140711 FORMER COMPANY: FORMER CONFORMED NAME: Kalani I Ltd DATE OF NAME CHANGE: 20140709 10-K 1 mdt-20240426.htm 10-K mdt-20240426 0001613103 4/26 false FY 2024 D02 XH02 P3Y http://fasb.org/us-gaap/2023#OtherOperatingIncomeExpenseNet http://fasb.org/us-gaap/2023#DebtCurrent http://fasb.org/us-gaap/2023#DebtCurrent P6Y P3Y P5Y P8Y P5Y P6Y P8Y P12Y P12Y P9Y P12Y P10Y P12Y P20Y P30Y P20Y P30Y P20Y P30Y P20Y P30Y P30Y P30Y P30Y P30Y P30Y http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligations http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligations http://fasb.org/us-gaap/2023#InterestExpense http://fasb.org/us-gaap/2023#OtherAssetsCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherAssetsCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherOperatingIncomeExpenseNet P10Y P4Y http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure mdt:tranche iso4217:EUR iso4217:JPY mdt:segment mdt:reportingUnit iso4217:EUR xbrli:shares mdt:plantiff mdt:claim mdt:lawsuit 0001613103 2023-04-29 2024-04-26 0001613103 us-gaap:CommonStockMember 2023-04-29 2024-04-26 0001613103 mdt:SeniorNotes2019Due2025Member 2023-04-29 2024-04-26 0001613103 mdt:SeniorNotes2020Due2025Member 2023-04-29 2024-04-26 0001613103 mdt:SeniorNotes2022Due2025Member 2023-04-29 2024-04-26 0001613103 mdt:SeniorNotes2019Due2027Member 2023-04-29 2024-04-26 0001613103 mdt:SeniorNotes2020Due2028Member 2023-04-29 2024-04-26 0001613103 mdt:SeniorNotes2022Due2028Member 2023-04-29 2024-04-26 0001613103 mdt:SeniorNotesDue2029Member 2023-04-29 2024-04-26 0001613103 mdt:SeniorNotes2019Due20311.625PercentMember 2023-04-29 2024-04-26 0001613103 mdt:SeniorNotes2019Due20311.00PercentMember 2023-04-29 2024-04-26 0001613103 mdt:SeniorNotes2022Due2031Member 2023-04-29 2024-04-26 0001613103 mdt:SeniorNotes2020Due2032Member 2023-04-29 2024-04-26 0001613103 mdt:SeniorNotes2022Due2034Member 2023-04-29 2024-04-26 0001613103 mdt:SeniorNotesDue2036Member 2023-04-29 2024-04-26 0001613103 mdt:SeniorNotes2019Due20392.250PercentMember 2023-04-29 2024-04-26 0001613103 mdt:SeniorNotes2019Due20391.50PercentMember 2023-04-29 2024-04-26 0001613103 mdt:SeniorNotes2020Due2040Member 2023-04-29 2024-04-26 0001613103 mdt:SeniorNotesDue2043Member 2023-04-29 2024-04-26 0001613103 mdt:SeniorNotes2019Due2049Member 2023-04-29 2024-04-26 0001613103 mdt:SeniorNotes2020Due2050Member 2023-04-29 2024-04-26 0001613103 mdt:SeniorNotesDue2053Member 2023-04-29 2024-04-26 0001613103 2023-10-27 0001613103 2024-06-17 0001613103 2022-04-30 2023-04-28 0001613103 2021-05-01 2022-04-29 0001613103 202